• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-erythropoietin antibodies and pure red cell aplasia.

作者信息

Rossert Jerome, Casadevall Nicole, Eckardt Kai-Uwe

机构信息

Department of Nephrology, Tenon hospital and Pierre and Marie Curie University, Paris, France.

出版信息

J Am Soc Nephrol. 2004 Feb;15(2):398-406. doi: 10.1097/01.asn.0000107561.59698.42.

DOI:10.1097/01.asn.0000107561.59698.42
PMID:14747386
Abstract
摘要

相似文献

1
Anti-erythropoietin antibodies and pure red cell aplasia.
J Am Soc Nephrol. 2004 Feb;15(2):398-406. doi: 10.1097/01.asn.0000107561.59698.42.
2
Red-cell aplasia due to antibodies against human recombinant erythropoietin (rHuEPO) in a peritoneal dialysis patient treated with rHuEPO.一名接受重组人促红细胞生成素（rHuEPO）治疗的腹膜透析患者，因抗重组人促红细胞生成素抗体导致的纯红细胞再生障碍。
Perit Dial Int. 2003 Jul-Aug;23(4):403-5.
3
Epoetin-induced autoimmune pure red cell aplasia.促红细胞生成素诱导的自身免疫性纯红细胞再生障碍。
J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S67-9. doi: 10.1681/asn.2004110959.
4
Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.抗体诱导的纯红细胞再生障碍性贫血后重组人促红细胞生成素的成功重新引入。
Nephrol Dial Transplant. 2004 Aug;19(8):2137-9. doi: 10.1093/ndt/gfh319.
5
Pure red-cell aplasia due to anti-erythropoietin antibodies.抗促红细胞生成素抗体所致的纯红细胞再生障碍性贫血。
Nephrol Dial Transplant. 2003 May;18(5):865-9. doi: 10.1093/ndt/gfg182.
6
Epoetin-induced autoimmune pure red cell aplasia.促红细胞生成素诱导的自身免疫性纯红细胞再生障碍
Hematol J. 2004;5 Suppl 3:S104-9. doi: 10.1038/sj.thj.6200433.
7
Pure red-cell aplasia induced by anti-erythropoietin antibodies in peritoneal dialysis.腹膜透析中抗促红细胞生成素抗体诱导的纯红细胞再生障碍
Clin Nephrol. 2004 Feb;61(2):155-8. doi: 10.5414/cnp61155.
8
Benefits of recombinant human erythropoietin.重组人促红细胞生成素的益处。
Lancet. 2002 Nov 16;360(9345):1606-7. doi: 10.1016/s0140-6736(02)11544-3.
9
Eprex (recombinant human erythropoietin alfa) and pure red cell aplasia--recommendations for administration to patients with CRF.益比奥（重组人促红细胞生成素α）与纯红细胞再生障碍性贫血——关于慢性肾衰竭患者给药的建议
S Afr Med J. 2003 Nov;93(11):839.
10
Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins.一名患有纯红细胞再生障碍性贫血且产生抗促红细胞生成素抗体的患者在用不同促红细胞生成素刺激时出现的过敏性皮肤和全身反应。
J Am Soc Nephrol. 2002 Sep;13(9):2381-3. doi: 10.1097/01.asn.0000027031.79843.6c.

引用本文的文献

1
Serum Anti-Erythropoietin Autoantibodies and Their Association With Younger Age in Paediatric Malaria Cases.血清抗促红细胞生成素自身抗体及其与儿童疟疾病例中较年轻年龄的关联。
Biomed Res Int. 2025 Oct 4;2025:8845434. doi: 10.1155/bmri/8845434. eCollection 2025.
2
UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease.英国肾脏协会临床实践指南：慢性肾脏病贫血的更新
BMC Nephrol. 2025 Apr 16;26(1):193. doi: 10.1186/s12882-025-04115-1.
3
Corticosteroid and immunosuppressive treatment are effective for acquired pure red cell aplasia in chronic kidney disease: a case report and literature review.
皮质类固醇和免疫抑制治疗对慢性肾脏病获得性纯红细胞再生障碍性贫血有效：一例报告及文献综述
Ren Fail. 2025 Dec;47(1):2449202. doi: 10.1080/0886022X.2024.2449202. Epub 2025 Jan 6.
4
What are clinically significant anti-drug antibodies and why is it important to identify them.什么是具有临床意义的抗药物抗体，以及识别它们为何重要。
Front Immunol. 2024 Dec 16;15:1401178. doi: 10.3389/fimmu.2024.1401178. eCollection 2024.
5
Positive response of a hemodialysis patient with pure red cell aplasia on recombinant human erythropoietin therapy to cyclosporine and Roxadustat.重组人红细胞生成素治疗伴纯红细胞再生障碍的血液透析患者对环孢素和罗沙司他的阳性反应。
CEN Case Rep. 2024 Dec;13(6):445-449. doi: 10.1007/s13730-024-00865-3. Epub 2024 Mar 25.
6
Targeting Progranulin as an Immuno-Neurology Therapeutic Approach.靶向颗粒蛋白前体作为一种免疫神经治疗方法。
Int J Mol Sci. 2023 Nov 3;24(21):15946. doi: 10.3390/ijms242115946.
7
Anti-cytokine autoantibodies: mechanistic insights and disease associations.抗细胞因子自身抗体：作用机制的深入了解和与疾病的关联。
Nat Rev Immunol. 2024 Mar;24(3):161-177. doi: 10.1038/s41577-023-00933-2. Epub 2023 Sep 19.
8
Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia.病例报告：罗沙司他联合利妥昔单抗用于治疗促红细胞生成素诱导的纯红细胞再生障碍。
Front Nephrol. 2022 Mar 24;2:847847. doi: 10.3389/fneph.2022.847847. eCollection 2022.
9
Successful application of roxadustat in the treatment of patients with anti-erythropoietin antibody-mediated renal anaemia: a case report and literature review.罗沙司他治疗抗红细胞生成素抗体介导的肾性贫血患者的成功应用：一例报告及文献复习。
J Int Med Res. 2021 Apr;49(4):3000605211005984. doi: 10.1177/03000605211005984.
10
Long-Term Patient-Customized Therapy for a Pathogenic Mutation.长期针对致病突变的个体化治疗。
Med. 2021 Jan 15;2(1):33-37.e1. doi: 10.1016/j.medj.2020.10.001. Epub 2020 Nov 9.